CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Yunnan Wenshan Kunqi Pharmaceutcl Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Yunnan Wenshan Kunqi Pharmaceutcl Co Ltd
4 km Yan Xi Road, Yanshan County
Phone: +86 8763138976p:+86 8763138976 WENSHAN, YUN  663100  China
Business Summary
Yunnan Wenshan Kunqi Pharmaceutical Co., Ltd. is mainly engaged in development, manufacturing and sales of Chinese herbal medicine. The Company’s main products contain direct taking pieces and ordinary pieces (net system). Direct taking pieces business is mainly engaged in the production of playing powder. Ordinary pieces business is mainly engaged in the production of net notoginseng pieces, which are primary cleaning dispensing pieces after initial processing. It has more than 10 kinds of Chinese herbal medicine based on Yunan local traditional Chinese medicine. The main products contain notoginseng powder, superfine notoginseng powder, cooked notoginseng powder, panax flowers, net notoginseng and other products.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201412/31/2014Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

General Information
Outstanding Shares: 8,130,000 (As of 12/31/2014)


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023